drugset / Trial / NCT00276094
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether ospemifene is more effective than placebo in the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women.
Timeline
- Start
- 2006-01
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ospemifene | Other / unclassified | 30 mg | Oral |
| Subject | Ospemifene | Other / unclassified | 60 mg | Oral |
| Background | K-Y® Brand Jelly | Unknown | — | — |